[ad_1]
◀ Anchor ▶
An interim result announced that the effectiveness of the COVID-19 vaccine, which is being jointly developed by Pfizer in the US and Bioentech in Germany, is more than 90% effective.
It’s a powerful effect that is twice as effective as the regular flu vaccine, but is still in clinical trials, so the final value may change.
Reporter Yoo Chung-hwan.
◀ Report ▶
Pfizer analyzed 94 people infected with Corona 19 among the participants in the phase 3 clinical trial and found that the company’s vaccine was effective in preventing more than 90%.
[앨버트 불라/화이자 CEO]“Today is a great day for science. It is a great day for humanity. I think we can see the light at the end of the tunnel.”
Pfizer and Bioentech divided the clinical trial participants into two groups, with vaccines given to one group and fake drugs to the other.
In the experimental group that received the vaccine, less than 10% were confirmed, while in the experimental group that received the fake drug, more than 90% were infected with Corona 19.
This announcement is an interim result of an external expert panel, the Data Watch Committee, regarding the phase 3 trial of Pfizer and Bioentech, and the final figure may be different.
The phase 3 trial, which began in July, is expected to continue until a total of 164 confirmed cases are reported.
Pfizer plans to apply for emergency use approval from the Food and Drug Administration in the third week of November.
The vaccine is expected to be manufactured in quantities capable of inoculating approximately 20 million people by the end of this year.
The confirmed corona19 number in the United States currently exceeds 10 million, and more than 240,000 have died.
In Europe, as the number of infections soared, the cumulative number of confirmed cases surpassed 12 million, and the number of confirmed corona 19 cases worldwide surpassed 50 million.
[앨버트 불라/화이자 CEO]“I don’t think it is Pfizer who will get the vaccine. The decision depends on the health authorities of each country and, in the case of the United States, the health authorities of each state.”
However, experts say the long-term safety of the vaccine has yet to be proven and is also the key to how long it will remain effective.
This is Yoo Chung-Hwan from MBC News.
MBC News is waiting for your report 24 hours a day.
▷ Telephone 02-784-4000
▷ Email [email protected]
▷ KakaoTalk report @mbc
